Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages

  Assie, Guillaume ^a,b,c   Louiset, Estelle ^d   Sturm, Nathalie ^e,g   René Corail, Fernande ^b   Groussin, Lionel ^a,b,c   Bertherat, Jérôme ^a,b,c   Thomas, Michaël ^g,h,i   Lefebvre, Hervé ^d,j   Feige, Jean Jacques ^g,h,i   Clauser, Eric ^a,b   Chabre, Olivier ^f,g,h,i   Cherradi, Nadia ^g,h,i  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c Institut Cochin   (France)

^d UNIVERSITÉ DE ROUEN   (France)

^e HÔPITAL MICHALLON   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UNIV GRENOBLE ALPES   (France)

^h INSERM   (France)

ⁱ CEA GRENOBLE   (France)

^j ROUEN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR 1; 4 AMINOBUTYRIC ACID B RECEPTOR 2; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; CLONIDINE; COMPLEMENTARY DNA; CORTICOTROPIN; G PROTEIN COUPLED RECEPTOR; HYDROCORTISONE; MESSENGER RNA; MLNR PROTEIN; MOTILIN; PROTEIN; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG; YOHIMBINE;

ADENOMA; ADRENAL CORTEX; ADRENAL GLAND; ADRENAL HYPERPLASIA; ADRENOCORTICOTROPIN INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; ARTICLE; CLINICAL ARTICLE; CORTISOL SECRETING ADENOMA; CUSHING SYNDROME; DRUG TARGETING; GENE EXPRESSION; GENETIC ASSOCIATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 77957771502     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2281     Document Type: Article

References (39)

1. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110 (Pubitemid 32187804)
2. Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, Bottari SP, Bachelot I, Chambaz EM, Defaye G, Feige JJ 1998 Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab 83:3134-3143
3. Mazzuco TL, Chabre O, Feige JJ, Thomas M 2006 Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J Clin Endocrinol Metab 91:196-203
4. Mazzuco TL, Chabre O, Feige JJ, Thomas M 2007 Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis. Mol Cell Endocrinol 265-266:23-28
5. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M 2006 Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147:782-790
6. Iacobone M, Albiger N, Scaroni C, Mantero F, Fassina A, Viel G, Frego M, Favia G 2008 The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg 32:882-889
7. Mazzuco TL, Chaffanjon P, Martinie M, Sturm N, Chabre O 2009 Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of beta-blockade therapy and interest of unilateral adrenalectomy. Endocr J 56:867-877
8. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H 2005 In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 90:1302-1310
9. Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ, Chabre O 2007 Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing β-blocker-sensitive Cushing's syndrome. Arq Bras Endocrinol Metab 51:1452-1462
10. 4 from random aggregation. J Mol Biol 47:69-85
11. Towbin H, Staehelin T, Gordon J 1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
12. Wang XL, Bassett M, Zhang Y, Yin S, Clyne C, White PC, Rainey WE 2000 Transcriptional regulation of human 11β-hydroxylase (hCYP11B1). Endocrinology 141:3587-3594
13. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, Kuhn JM, Lacroix A, Tabarin A, Young J, Vaudry H, Lefebvre H 2003 Overexpression of serotonin 4 receptors in cisapride-responsive adrenocorticotropin- independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 88:248-254 (Pubitemid 36115174)
14. Larsen P, Kronenberg H, Melmed S, Polonsky K 2003 William's textbook of endocrinology. 10th edition. Philadelphia: Saunders
15. Moura E, Afonso J, Hein L, Vieira-Coelho MA 2006 α2-Adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice. Br J Pharmacol 149:1049-1058
16. Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A 2006 Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 64:29-36
17. Lebrethon MC, Naville D, Begeot M, Saez JM 1994 Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 93:1828-1833
18. Depoortere I, Peeters TL 1995 Transduction mechanism of motilin and motilides in rabbit duodenal smooth muscle. Regul Pept 55:227-235
19. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, Nargund R, Bakshi R, Abramovitz M, Stocco R, Kargman S, O'Neill G, Van Der Ploeg LH, Evans J, Patchett AA, Smith RG, Howard AD 1999 Receptor for motilin identified in the human gastrointestinal system. Science 284:2184-2188
20. Huang J, Zhou H, Mahavadi S, Sriwai W, Lyall V, Murthy KS 2005 Signaling pathways mediating gastrointestinal smooth muscle contraction and MLC20 phosphorylation by motilin receptors. Am J Physiol Gastrointest Liver Physiol 288:G23-G31
21. De Smet B, Mitselos A, Depoortere I 2009 Motilin and ghrelin as prokinetic drug targets. Pharmacol Ther 123:207-223
22. Bittiger H, Froestl W, Mickel S, Olpe HR 1993 GABAB receptor antagonists: from synthesis to therapeutic applications. Trends Pharmacol Sci 14:391-394
23. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C 1998 GABA(B) receptors function as a heteromeric assembly of the subunitsGABA(B)R1and GABA(B)R2. Nature 396:674-679
24. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B 1998 GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687
25. Jaiswal N, Sharma RK 1986 Dual regulation of adenylate cyclase and guanylate cyclase: α2-adrenergic signal transduction in adrenocortical carcinoma cells. Arch Biochem Biophys 249:616-619
26. Contesse V, Reznik Y, Louiset E, Duparc C, Cartier D, Sicard F, Laquerriere A, Parmentier F, Kuhn JM, Vaudry H, Lefebvre H 2005 Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. J Clin Endocrinol Metab 90:2843-2850
27. Lefebvre H, Duparc C, Chartrel N, Jegou S, Pellerin A, Laquerriere A, Ivell R, Vaudry H, Kuhn JM 2003 Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 88:3035-3042
28. Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Barrande G, Bertherat J, Vaudry H, Lefebvre H 2006 Expression of serotonin 7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 91:4578-4586
29. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR 1992 Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits. Nature 356:159-161
30. Chabre O, Conklin BR, Brandon S, Bourne HR, Limbird LE 1994 Coupling of the α2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. J Biol Chem 269:5730-5734
31. Eason MG, Kurose H, Holt BD, Raymond JR, Liggett SB 1992 Simultaneous coupling of α2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of α2C10, α2C4, and α2C2 adrenergic receptors to Gi and Gs. J Biol Chem 267:15795-15801
32. Eason MG, Liggett SB 1995 Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the α2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling. J Biol Chem 270:24753-24760
33. Fraser CM, Arakawa S, McCombie WR, Venter JC 1989 Cloning, sequence analysis, and permanent expression of a human α2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J Biol Chem 264:11754-11761
34. Dorn 2nd GW, Oswald KJ, McCluskey TS, Kuhel DG, Liggett SB 1997 α2A-Adrenergic receptor stimulated calcium release is transduced by Gi-associated G(βγ)-mediated activation of phospholipase C. Biochemistry 36:6415-6423
35. Schaak S, Cussac D, Cayla C, Devedjian JC, Guyot R, Paris H, Denis C 2000 α(2) Adrenoceptors regulate proliferation of human intestinal epithelial cells. Gut 47:242-250
36. Tam SW, Worcel M, Wyllie M 2001 Yohimbine: a clinical review. Pharmacol Ther 91:215-243
37. Le Corre P, Dollo G, Chevanne F, Le Verge R 1999 Biopharmaceutics and metabolism of yohimbine in humans. Eur J Pharm Sci 9:79-84
38. Crassous PA, Denis C, Paris H, Sénard JM 2007 Interest of α2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem 7:187-194
39. Pertovaara A, Haapalinna A, Sirviö J, Virtanen R 2005 Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective α2-adrenoceptor antagonist. CNS Drug Rev 11:273-288